|
|
|
|
|
|
|
Intersect ENT Inc. (XENT)
|
|
30.945 0.415 (1.36%)
|
11-16 11:20
|
|
Open:
|
30.28
|
Pre. Close:
|
30.53
|
|
High:
|
30.99
|
Low:
|
29.93
|
|
Volume:
|
29,166
|
Market Cap:
|
946M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
31.213 - 31.392
|
31.392 - 31.554
|
|
Low:
|
28.747 - 28.933
|
28.933 - 29.101
|
|
Close:
|
30.251 - 30.562
|
30.562 - 30.842
|
|
|
|
Technical analysis (as of: 2018-11-16 10:27:20 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 39.49 One year: 46.12
|
|
Support:
|
Support1: 28.80 Support2: 25.70
|
|
Resistance:
|
Resistance1:
33.81 Resistance2: 39.49
|
|
Pivot:
|
29.94
|
|
Moving Averages:
|
MA(5): 30.34  MA(20): 29.28
MA(100): 29.93 MA(250): 33.99
|
|
MACD:
|
MACD(12,26):
0.54 Signal(12,26,9): 0.43
|
|
%K %D:
|
%K(14,3): 59.84 %D(3): 58.45
|
|
RSI:
|
RSI(14): 53.47
|
|
52-Week:
|
High: 42.95
Low: 25.15 Change(%): 5.6
|
|
Average Vol(K):
|
3-Month: 34721
10-Days 48938
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.XENT has closed below upper band by 43.6%. Bollinger Bands are 53.4% wider than normal. The large width of the bands suggest high volatility as compared to XENT's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-11-15T16:30:07-05:00
Pooled data show treatment value of Intersect ENT sinus implants
2018-11-15T16:06:00-05:00
Intersect ENT Announces Publication of Pooled Analysis of Steroid Releasing Implants in Patients Following Frontal Sinus Surgery
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
